1. Barnes P. Respiratory Pharmacology: General Pharmacologic Principles // Murray & Nadel: Textbook of Respiratory Medicine, 3rd ed. - W. B. Saunders Company, 2000. - 232 р.
2. Guyton A.C. Textbook of medical physiology. - Philadelphia, 1986.
3. Johnson M. The beta-adrenoceptor //Am J Respir Crit Care Med. - 1998, Nov. - 158 (5 Pt 3). - S 146-153.
5. Barnes P. Effect of beta agonists on inflammatory cells // J. Allergy Clin. Immunol. - 1999, 104 (2), 10-17.
6. McGraw D.W., Liggett S.B. Molecular mechanisms of beta2-adrenergic receptor function and regulation // Proc Am Thorac Soc. - 2005. - N. 2(4). - Р. 292-296.
7. Van Veen A., Weller F.R., Wierenga E.A. et al. A comparison of salmeterol and formoterol in attenuating airway responses to short-acting beta2-agonists.
8. Tan K.S., Grove A., McLean A., Gnosspelius Y., Hall I.P., Lipworth B.J. Systemic corticosteriod rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients // Am J Respir Crit Care Med. - 1997, Jul. - N. 156(1). - Р. 28-35.
9. Hanania N.A., Sharafkhaneh A., Barber R., Dickey B.F. Beta-agonist intrinsic efficacy: measurement and clinical significance // Am J Respir Crit Care Med. - 2002, May 15 - N. 165(10). - Р. 1353-1358.
10. Scola A-M., Chong L.K., Suvarna K. et al. Desensitisation of mast cell b2-adrenoceptor-mediated responses by salmeterol and formoterol // British Journal of Pharmacology. - 2004. - N. 141. - Р. 163-171.
11. Boonsawat W. et al. // Respir Med. - 2003. - N. 97. - Р. 1067-1074.
12. Bateman E.D., Fairall L., Lombardi D.M., English R. // Respiratory Research. - 2006. - N. 7. - Р. 13.
13. Sears M.R. The evolution of beta2-agonists // Respir Med. - 2001, Aug. - N. 95 (Suppl B). - S2-6.
14. Anderson G.P., Linden A., Rabe K.F. Why are long-acting beta-adrenoceptor agonists long-acting? // Eur Respir J. - 1994. - N. 7. - Р. 569-578.